Label Changes for:

Relistor (methylnaltrexone bromide) Subcutaneous injection

November 2009

Changes have been made to the ADVERSE REACTIONS and PATIENT PACKAGE INSERT sections of the safety label.

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) – November 2009

ADVERSE REACTIONS

  • hyperhidrosis

PATIENT INFORMATION

What are the possible side effects of Relistor?
  • Sweating
Hide
(web5)